Objective
To observe the clinical manifestations and treatment of ocular myasthenia gravis.
Methods
The clinical manifestations, results of laboratory examination and thymic CT, and
therapeutic data of 84 patients with ocular myasthenia gravis, hospitalized from
July, 1998 to July, 2005, were retrospective ly analyzed.
Results
These patients were 2.5 to 70 years old. All of the patients had ptosis, includine
35.77% with diplopia 25% with strabismus; 1 with obnormal sphincter muscle
and 1 with blurry vision.The positive rate of examination of AchR antibody was
27.6%, and abnormal rate of examination of thymic CT was 64.3%. The cure rate was 48.1% in oral administration with tabellae in whomdostigmini group, 66.7%
in methylprednisolonum hormone therapy group, and 51.9%in thymectomy group.
Conclusions
Ocular myasthenia gravis is mostly involved levator palpebrae superiors and
sometimes also involved other ocular muscles. Anticholinesterase medication,
methylprednisolonum hormone therapy or thymec tomy are effective.
(Chin J Ocul Fundus Dis, 2006,22:379-381)
